Ara
Toplam kayıt 39, listelenen: 21-30
Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics
(Lippincott Williams & Wilkins, 2015)
Management Dilemma in Acute Prosthetic Valve Thrombosis: Surgery or Thrombolysis?
(Wiley-Blackwell, 2015)
Bridging anticoagulation in patients with mechanical heart valves
(Elsevier Ireland Ltd, 2017)
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
(Turkish Soc Cardiology, 2016)
Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ...
Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor
PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study)
(Sage Publications Inc, 2017)
Introduction: Inappropriate use of oral anticoagulants (OACs) have not been well investigatedand, however, may be frequent in real-world practice in patients with nonvalvular atrial fibrillation (NVAF). This study was ...
What Is the Optimal Timing for Surgical Treatment of Infective Endocarditis?
(Elsevier Science Inc, 2015)
Criteria for Prescribing Dabigatrin Extexilate and Rivaroxaban Really Appropriate? Comment
(Sage Publications Inc, 2015)
Increased Epicardial Fat Thickness Correlates with Aortic Stiffness and N-Terminal Pro-Brain Natriuretic Peptide Levels in Acute Ischemic Stroke Patients
(Texas Heart Inst, 2016)
Epicardial fat, a metabolically active tissue, has emerged as a risk factor and active player in metabolic and cardiovascular diseases. We investigated epicardial fat thickness in patients who had sustained an acute ischemic ...
Switching among oral anticoagulants: is it logical?
(Taylor & Francis Ltd, 2020)